4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-24-024044
Director bought 666,665 shares at $18.00 ($11,999,970)
- Director acquired 1,638,236 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
HEALY JAMES · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-27 | Conversion : show line 1 in the form | +1,638,236 | 1,638,236 | I | ||
| 2024-09-27 | Purchase : show line 2 in the form | +588,888 | $18.00 | $10,599,984 | 2,227,124 | I |
| 2024-09-27 | Purchase : show line 3 in the form | +11,113 | $18.00 | $200,034 | 11,113 | I |
| 2024-09-27 | Purchase : show line 4 in the form | +18,353 | $18.00 | $330,354 | 18,353 | I |
| 2024-09-27 | Purchase : show line 5 in the form | +21,814 | $18.00 | $392,652 | 21,814 | I |
| 2024-09-27 | Purchase : show line 6 in the form | +26,497 | $18.00 | $476,946 | 26,497 | I |
| Open-market purchases · 666,665 sh · avg $18.00 · $11,999,970 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-25 | Grant or award : show line 7 in the form Stock Option (Right to Buy) | +15,000 | 15,000 | D |
| 2024-09-27 | Conversion : show line 8 in the form Series D Preferred Stock | −7,310,796 | 0 | I |
Loading xslF345X05/form4-09272024_080939.xml…